Remove wednesday-night
article thumbnail

Sen. John Fetterman is receiving treatment for clinical depression

NPR Health - Shots

The Pennsylvania Democrat checked himself into Walter Reed hospital on Wednesday night. Image credit: Alex Wong/Getty Images)

110
110
article thumbnail

Eye drops linked to U.S. drug-resistant bacteria outbreak

STAT News

The Centers for Disease Control and Prevention on Wednesday night sent a health alert to physicians, saying the outbreak includes at least 55 people in 12 states. NEW YORK — U.S. health officials are advising people to stop using over-the-counter eye drops that have been linked to an outbreak of drug-resistant infections.

Bacteria 126
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Federal judge dismisses doctor’s case that argued surprise billing law was unconstitutional

STAT News

The decision , issued Wednesday night by Judge Ann Donnelly in the federal Eastern District of New York, keeps billing protections intact for patients and quashes an attempt to kill a law that had overwhelming bipartisan support in Congress.

98
article thumbnail

Biden Proposes New $6.5 Billion Advanced Research Agency to End Cancer

BioSpace

As President Joe Biden said Wednesday night in his first major speech to Congress, “I know of nothing that is more bipartisan.” Cancer doesn’t care if you’re Democratic, Republican, Libertarian or Green. It strikes without prejudice or consideration.

article thumbnail

Xtalks Speaks with Astellas Pharma’s VP & Head of BioPharma Development Marci English About Menopause Drug Approval – Xtalks Life Science Podcast Ep. 116

XTalks

This episode features an interview with Marci English, Vice President and Head of BioPharma Development at Astellas Pharma, about the recent FDA approval of the company’s drug Veozah (fezolinetant) for the treatment of moderate to severe hot flashes and night sweats due to menopause.

article thumbnail

Veozah the New Drug for Menopausal Hot Flashes + SkinVive the New Dermal Filler — Xtalks Life Science Podcast Ep. 111

XTalks

In this episode, Vera talked about the US Food and Drug Administration’s (FDA) approval of Veozah (fezolinetant), the new type of drug for menopausal hot flashes and night sweats. It is estimated that around 60 to 80 percent of women experience vasomotor symptoms (hot flashes, night sweats, etc.)

Filler 52
article thumbnail

Permanent Night Shift Workers at Higher Risk for Asthma

The Pharma Data

Permanent Night Shift Workers at Higher Risk for Asthma. WEDNESDAY, Nov. 18, 2020 — Shift workers, especially those working permanent night shifts, have an increased risk for moderate-severe asthma and all asthma, according to a study published online Nov. Professional. 16 in Thorax. Robert Maidstone, Ph.D.,